Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/mcp.M700354-MCP200 on October 15, 2007.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M700354-MCP200v1
6/12/2212    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keshishian, H.
Right arrow Articles by Carr, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keshishian, H.
Right arrow Articles by Carr, S. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 6:2212-2229, 2007.
© 2007 by The American Society for Biochemistry and Molecular Biology, Inc.


Research

Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*,S

Hasmik Keshishian{ddagger}, Terri Addona{ddagger}, Michael Burgess, Eric Kuhn and Steven A. Carr§

From the Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts 02142

Biomarker discovery produces lists of candidate markers whose presence and level must be subsequently verified in serum or plasma. Verification represents a paradigm shift from unbiased discovery approaches to targeted, hypothesis-driven methods and relies upon specific, quantitative assays optimized for the selective detection of target proteins. Many protein biomarkers of clinical currency are present at or below the nanogram/milliliter range in plasma and have been inaccessible to date by MS-based methods. Using multiple reaction monitoring coupled with stable isotope dilution mass spectrometry, we describe here the development of quantitative, multiplexed assays for six proteins in plasma that achieve limits of quantitation in the 1–10 ng/ml range with percent coefficients of variation from 3 to 15% without immunoaffinity enrichment of either proteins or peptides. Sample processing methods with sufficient throughput, recovery, and reproducibility to enable robust detection and quantitation of candidate biomarker proteins were developed and optimized by addition of exogenous proteins to immunoaffinity depleted plasma from a healthy donor. Quantitative multiple reaction monitoring assays were designed and optimized for signature peptides derived from the test proteins. Based upon calibration curves using known concentrations of spiked protein in plasma, we determined that each target protein had at least one signature peptide with a limit of quantitation in the 1–10 ng/ml range and linearity typically over 2 orders of magnitude in the measurement range of interest. Limits of detection were frequently in the high picogram/milliliter range. These levels of assay performance represent up to a 1000-fold improvement compared with direct analysis of proteins in plasma by MS and were achieved by simple, robust sample processing involving abundant protein depletion and minimal fractionation by strong cation exchange chromatography at the peptide level prior to LC-multiple reaction monitoring/MS. The methods presented here provide a solid basis for developing quantitative MS-based assays of low level proteins in blood.


§ To whom correspondence should be addressed. Tel.: 617-324-9762; Fax: 617-252-1902; E-mail: scarr{at}broad.mit.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
S. Makawita and E. P. Diamandis
The Bottleneck in the Cancer Biomarker Pipeline and Protein Quantification through Mass Spectrometry-Based Approaches: Current Strategies for Candidate Verification
Clin. Chem., February 1, 2010; 56(2): 212 - 222.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. E. Gerszten, S. A. Carr, and M. Sabatine
Integration of Proteomic-Based Tools for Improved Biomarkers of Myocardial Injury
Clin. Chem., February 1, 2010; 56(2): 194 - 201.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. E. Abbatiello, D. R. Mani, H. Keshishian, and S. A. Carr
Automated Detection of Inaccurate and Imprecise Transitions in Peptide Quantification by Multiple Reaction Monitoring Mass Spectrometry
Clin. Chem., February 1, 2010; 56(2): 291 - 305.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
H. Keshishian, T. Addona, M. Burgess, D. R. Mani, X. Shi, E. Kuhn, M. S. Sabatine, R. E. Gerszten, and S. A. Carr
Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution
Mol. Cell. Proteomics, October 1, 2009; 8(10): 2339 - 2349.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. Tong, P. Taylor, S. M. Peterman, A. Prakash, and M. F. Moran
Epidermal Growth Factor Receptor Phosphorylation Sites Ser991 and Tyr998 Are Implicated in the Regulation of Receptor Endocytosis and Phosphorylations at Ser1039 and Thr1041
Mol. Cell. Proteomics, September 1, 2009; 8(9): 2131 - 2144.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. Sherman, M. J. McKay, K. Ashman, and M. P. Molloy
Unique Ion Signature Mass Spectrometry, a Deterministic Method to Assign Peptide Identity
Mol. Cell. Proteomics, September 1, 2009; 8(9): 2051 - 2062.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M. A. Kuzyk, D. Smith, J. Yang, T. J. Cross, A. M. Jackson, D. B. Hardie, N. L. Anderson, and C. H. Borchers
Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma
Mol. Cell. Proteomics, August 1, 2009; 8(8): 1860 - 1877.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. W. Buczynski, D. S. Dumlao, and E. A. Dennis
Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology
J. Lipid Res., June 1, 2009; 50(6): 1015 - 1038.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
E. Kuhn, T. Addona, H. Keshishian, M. Burgess, D.R. Mani, R. T. Lee, M. S. Sabatine, R. E. Gerszten, and S. A. Carr
Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry
Clin. Chem., June 1, 2009; 55(6): 1108 - 1117.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
N. L. Anderson, N. G. Anderson, T. W. Pearson, C. H. Borchers, A. G. Paulovich, S. D. Patterson, M. Gillette, R. Aebersold, and S. A. Carr
A Human Proteome Detection and Quantitation Project
Mol. Cell. Proteomics, May 1, 2009; 8(5): 883 - 886.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
N. L. Anderson, A. Jackson, D. Smith, D. Hardie, C. Borchers, and T. W. Pearson
SISCAPA Peptide Enrichment on Magnetic Beads Using an In-line Bead Trap Device
Mol. Cell. Proteomics, May 1, 2009; 8(5): 995 - 1005.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
T. Fortin, A. Salvador, J. P. Charrier, C. Lenz, X. Lacoux, A. Morla, G. Choquet-Kastylevsky, and J. Lemoine
Clinical Quantitation of Prostate-specific Antigen Biomarker in the Low Nanogram/Milliliter Range by Conventional Bore Liquid Chromatography-Tandem Mass Spectrometry (Multiple Reaction Monitoring) Coupling and Correlation with ELISA Tests
Mol. Cell. Proteomics, May 1, 2009; 8(5): 1006 - 1015.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. A. Mead, L. Bianco, V. Ottone, C. Barton, R. G. Kay, K. S. Lilley, N. J. Bond, and C. Bessant
MRMaid, the Web-based Tool for Designing Multiple Reaction Monitoring (MRM) Transitions
Mol. Cell. Proteomics, April 1, 2009; 8(4): 696 - 705.
[Abstract] [Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
A. K. Yocum and A. M. Chinnaiyan
Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry
Briefings in Functional Genomics, March 11, 2009; (2009) eln056v1.
[Abstract] [Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
X. Ye, J. Blonder, and T. D. Veenstra
Targeted proteomics for validation of biomarkers in clinical samples
Briefings in Functional Genomics, March 1, 2009; 8(2): 126 - 135.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. Kuno, Y. Kato, A. Matsuda, M. K. Kaneko, H. Ito, K. Amano, Y. Chiba, H. Narimatsu, and J. Hirabayashi
Focused Differential Glycan Analysis with the Platform Antibody-assisted Lectin Profiling for Glycan-related Biomarker Verification
Mol. Cell. Proteomics, January 1, 2009; 8(1): 99 - 108.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. A. Carr and L. Anderson
Protein Quantitation through Targeted Mass Spectrometry: The Way Out of Biomarker Purgatory?
Clin. Chem., November 1, 2008; 54(11): 1749 - 1752.
[Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
D. B. Martin, T. Holzman, D. May, A. Peterson, A. Eastham, J. Eng, and M. McIntosh
MRMer, an Interactive Open Source and Cross-platform System for Data Extraction and Visualization of Multiple Reaction Monitoring Experiments
Mol. Cell. Proteomics, November 1, 2008; 7(11): 2270 - 2278.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. N. Hoofnagle, J. O. Becker, M. H. Wener, and J. W. Heinecke
Quantification of Thyroglobulin, a Low-Abundance Serum Protein, by Immunoaffinity Peptide Enrichment and Tandem Mass Spectrometry
Clin. Chem., November 1, 2008; 54(11): 1796 - 1804.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
G. R. Nicol, M. Han, J. Kim, C. E. Birse, E. Brand, A. Nguyen, M. Mesri, W. FitzHugh, P. Kaminker, P. A. Moore, et al.
Use of an Immunoaffinity-Mass Spectrometry-based Approach for the Quantification of Protein Biomarkers from Serum Samples of Lung Cancer Patients
Mol. Cell. Proteomics, October 1, 2008; 7(10): 1974 - 1982.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. D. Jaffe, H. Keshishian, B. Chang, T. A. Addona, M. A. Gillette, and S. A. Carr
Accurate Inclusion Mass Screening: A Bridge from Unbiased Discovery to Targeted Assay Development for Biomarker Verification
Mol. Cell. Proteomics, October 1, 2008; 7(10): 1952 - 1962.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
W.-J. Qian, D. T. Kaleta, B. O. Petritis, H. Jiang, T. Liu, X. Zhang, H. M. Mottaz, S. M. Varnum, D. G. Camp II, L. Huang, et al.
Enhanced Detection of Low Abundance Human Plasma Proteins Using a Tandem IgY12-SuperMix Immunoaffinity Separation Strategy
Mol. Cell. Proteomics, October 1, 2008; 7(10): 1963 - 1973.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
S. Decramer, A. G. de Peredo, B. Breuil, H. Mischak, B. Monsarrat, J.-L. Bascands, and J. P. Schanstra
Urine in Clinical Proteomics
Mol. Cell. Proteomics, October 1, 2008; 7(10): 1850 - 1862.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. E. Gerszten, F. Accurso, G. R. Bernard, R. M. Caprioli, E. W. Klee, G. G. Klee, I. Kullo, T. A. Laguna, F. P. Roth, M. Sabatine, et al.
Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs
Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L16 - L22.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement